A Pharma Data Platform's AI Agent Was Working. We Rebuilt It Anyway.
How a live AI system on a pharmaceutical market access platform was rebuilt on its own knowledge foundation, and single answers became a working dialogue with the data.
Read more →Stay Ahead with Artificial Intelligence
AI is evolving at lightning speed. You need more than just news—you need insights that matter. Prosperaize brings you expert analysis, deep research, and real-world applications of AI that help you stay ahead of the curve.
Sep 22, 2026
Should You Invest in AI Yet? An Honest Answer for Manufacturers
Judge it the way you'd judge a machine. There are four questions, and your answers decide whether you're buying an asset or a write-off.
Read more →The Missing Layer Between Decisions and Action
Access isn't the same as follow-through. Finding information is one problem. Getting the right person to act on it is another.
Read more →AI Doesn't Reward Risk. It Punishes Bad Scoping.
Before you fund it, score your project on these ten dimensions. Or accept the downside.
Read more →If Your Data Isn't AI-Ready, Neither Is Your Initiative
Data readiness — not data existence — determines whether an AI initiative ships. Five practices that turn an existing data environment into one AI systems can actually use.
Read more →Users Could Find Any Record on a Pharma Data Platform. They Couldn't Get an Answer Out of It.
How we replaced a failing SQL agent and gave Pharma Market Access teams insights across 90+ jurisdictions in seconds.
Read more →The Real Reason 90% of AI Initiatives Don't Become Profit-Generating Assets
AI assets demand a breadth of expertise that no single role, team, or department was ever designed to carry. Here's what actually goes wrong and why.
Read more →The Hidden ROI Killer in AI Projects: Starting With the Solution
Most AI investment failures are decided in the first two weeks. This is how you ensure those two weeks are used wisely.
Read more →